Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | CA7 | P43166 | 1/20 | 0.54 |
| ▸ | CA9 | Q16790 | 1/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | LMNA | P02545 | 4/20 | 0.50 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | MDM2 | Q00987 | 2/20 | 0.48 |
| ▸ | MMP1 | P03956 | 1/20 | 0.48 |
| ▸ | MMP2 | P08253 | 1/20 | 0.48 |
| ▸ | MMP9 | P14780 | 1/20 | 0.48 |
| ▸ | MMP12 | P39900 | 1/20 | 0.48 |
| ▸ | MDM4 | O15151 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4106021 | 1.00 | CA12 (0.54) | CA12CA1CA2CA7CA9 | |
| SCHEMBL4106013 | 1.00 | CA12 (0.54) | CA12CA1CA2CA7CA9 | |
| SCHEMBL12809162 | 1.00 | CA12 (0.54) | CA12CA1CA2CA7CA9 | |
| SCHEMBL11230445 | 0.92 | LMNA (0.57) | CA12CA7CA9CA14MAPT | |
| SCHEMBL11230448 | 0.87 | HCAR2 (0.56) | CA12CA7CA9CA14MAPT | |
| SCHEMBL11230453 | 0.87 | HCAR2 (0.56) | CA12CA7CA9CA14MAPT | |
| SCHEMBL112366 | 0.87 | LMNA (0.65) | CA12CA7CA9CA14MAPT | |
| SCHEMBL112365 | 0.87 | LMNA (0.65) | CA12CA7CA9CA14MAPT | |
| SCHEMBL1532460 | 0.87 | LMNA (0.65) | CA12CA7CA9CA14MAPT | |
| SCHEMBL827239 | 0.87 | LMNA (0.65) | CA12CA7CA9CA14MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090047223-A1 | Improvements in or Related to Organic Compoounds | GIVAUDAN SA (CH) | 2009-02-19 | — | — | US | claimed |
| EP-1966117-A1 | IMPROVEMENTS IN OR RELATED TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2008-09-10 | — | — | EP | claimed |
| WO-2007071085-A1 | IMPROVEMENTS IN OR RELATED TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2007-06-28 | — | — | WO | claimed |
| US-20090047223-A1 | Improvements in or Related to Organic Compoounds | GIVAUDAN SA (CH) | 2009-02-19 | — | — | US | disclosed |
| EP-1966117-A1 | IMPROVEMENTS IN OR RELATED TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2008-09-10 | — | — | EP | disclosed |
| WO-2007071085-A1 | IMPROVEMENTS IN OR RELATED TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2007-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090047223-A1 | Improvements in or Related to Organic Compoounds | LPO, OTC, OAT | CA12 519/4885CA1 1217/4885CA2 1007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.